[1]https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2024-06-26-28/04-RSV-Adult-Das-508.pdf [2]https://www.fiercepharma.com/pharma/cdc-immunization-committee-votes-shrink-recommended-age-group-rsv-vaccination Copyright © 2024 PHARMCUBE. All Rights Reserved. 欢迎转发分享及合理引用...
Besides very young children, the age group at highest risk of severe RSV is adults who are: 25-40 40-55 Over 65 3/10 If you have RSV, you are commonly most contagious for 48 hours 3-7 days 4 weeks 4/10 True or false: Once you get RSV, you can’t get it again. True False ...
[9] Castro-Rodríguez JA, Holberg CJ, Wright AL, et al. Association of radiologically ascertained pneumonia before age 3 yr with asthma like symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med 1999; 159: 1891–97. [10] Turi KN, Shankar J, And...
The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of severe RSV, the company said Friday, making it the first shot greenlit for use in this age group to guard against RSV. Global ...
A study by the University of Strathclyde and Public Health Scotland (PHS) shows a 62% reduction in hospitalizations related torespiratory syncytial virus(RSV) among the eligible age group following introduction of the program in August 2024. ...
Based on the Navarre data, considering these risk groups as target groups would involve immunizing only 13% of people aged 60 years and older, but would address half of RSV hospitalizations in this age group, and could substantially reduce the burden of RSV on health care systems and RSV-rel...
Dr Tina Hartert Among the most notable findings, she writes, is the heavy mortality in the 0- to 6-month age group, which she notes is "the age group targeted by vaccination during pregnancy and birth-dose immunoprophylaxis."
The benefit was especially plain among the most vulnerable age group, those aged 75 and older. The new findings were published Oct. 18 inThe Lancet. "We were able to use the power of big data to determine RSV vaccine effectiveness, information [that is] needed to inform vaccine policy,” ...
10,11,14-17 On May 3, 2023, GSK’s adjuvanted RSV vaccine (Arexvy) became the first RSV vaccine to receive FDA approval for use in this age group.12 And, on May 31, 2023, Pfizer's bivalent, RSV prefusion F protein-based (RSVpreF) candidate (Abrysvo) became the second vaccine to...
If you’re particularly vulnerable to developing serious complications of RSV, like you haveasthmaor another lung condition, Russo recommends considering masking up around young kids, given how much RSV is spreading in that age group. “You definitely don’t want to interact with children that are...